You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 2, 2024

LOPERAMIDE HYDROCHLORIDE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Loperamide Hydrochloride patents expire, and what generic alternatives are available?

Loperamide Hydrochloride is a drug marketed by Aurobindo Pharma Ltd, Bionpharma, Chartwell Rx, Edenbridge Pharms, Jubilant Cadista, Mylan, Roxane, Rubicon, Strides Pharma, Teva, Zydus Lifesciences, Allied, Alpharma Us Pharms, Duramed Pharms Barr, Perrigo, Sciegen Pharms Inc, Watson Labs, Wockhardt Bio Ag, Perrigo R And D, Able, Aurobindo Pharma, Contract Pharmacal, L Perrigo Co, LNK, Ohm Labs, Granules, Guardian Drug, Hetero Labs Ltd V, and Sun Pharm Inds Ltd. and is included in thirty-seven NDAs.

The generic ingredient in LOPERAMIDE HYDROCHLORIDE is loperamide hydrochloride; simethicone. There are eleven drug master file entries for this compound. Thirty-one suppliers are listed for this compound. Additional details are available on the loperamide hydrochloride; simethicone profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Loperamide Hydrochloride

A generic version of LOPERAMIDE HYDROCHLORIDE was approved as loperamide hydrochloride; simethicone by PERRIGO R AND D on September 5th, 2018.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for LOPERAMIDE HYDROCHLORIDE?
  • What are the global sales for LOPERAMIDE HYDROCHLORIDE?
  • What is Average Wholesale Price for LOPERAMIDE HYDROCHLORIDE?
Drug patent expirations by year for LOPERAMIDE HYDROCHLORIDE
Recent Clinical Trials for LOPERAMIDE HYDROCHLORIDE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Uniformed Services University of the Health SciencesPhase 4
Infectious Diseases Clinical Research ProgramPhase 4
Henry M. Jackson Foundation for the Advancement of Military MedicinePhase 4

See all LOPERAMIDE HYDROCHLORIDE clinical trials

Pharmacology for LOPERAMIDE HYDROCHLORIDE
Drug ClassOpioid Agonist
Mechanism of ActionOpioid Agonists
Medical Subject Heading (MeSH) Categories for LOPERAMIDE HYDROCHLORIDE

US Patents and Regulatory Information for LOPERAMIDE HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Aurobindo Pharma Ltd LOPERAMIDE HYDROCHLORIDE AND SIMETHICONE loperamide hydrochloride; simethicone TABLET;ORAL 211059-001 Dec 14, 2020 OTC No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Lnk LOPERAMIDE HYDROCHLORIDE loperamide hydrochloride TABLET;ORAL 076497-001 Jun 10, 2003 OTC No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Bionpharma LOPERAMIDE HYDROCHLORIDE AND SIMETHICONE loperamide hydrochloride; simethicone TABLET;ORAL 213484-001 Sep 10, 2021 OTC No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Ohm Labs LOPERAMIDE HYDROCHLORIDE loperamide hydrochloride TABLET;ORAL 074091-001 Dec 10, 1992 OTC No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Aurobindo Pharma Ltd LOPERAMIDE HYDROCHLORIDE loperamide hydrochloride CAPSULE;ORAL 218122-001 Sep 5, 2023 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Perrigo LOPERAMIDE HYDROCHLORIDE loperamide hydrochloride SOLUTION;ORAL 073243-001 Jan 21, 1992 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Able LOPERAMIDE HYDROCHLORIDE loperamide hydrochloride TABLET;ORAL 073528-001 Nov 30, 1993 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.